Selected article for: "action mechanism and health disease"
Author: Hushmandi, Kiavash; Bokaie, Saied; Hashemi, Mehrdad; Moghadam, Ebrahim Rahmani; Raei, Mehdi; Hashemi, Farid; Bagheri, Mahdi; Habtemariam, Solomon; Nabavi, Seyed Mohammad
Title: A review of medications used to control and improve the signs and symptoms of COVID-19 patients
  • Cord-id: 5n87rsus
  • Document date: 2020_9_19
    • ID: 5n87rsus
    Snippet: In December 2019, an unprecedented outbreak of pneumonia associated with a novel coronavirus disease 2019 (COVID-19) emerged in Wuhan City, Hubei province, China. The virus that caused the disease was officially named by the World Health Organization (WHO) as the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). According to the high transmission rate of SARS-CoV-2, it became a global pandemic and public health emergency within few months. Since SARS-CoV-2 is genetically 80% homologo
    Document: In December 2019, an unprecedented outbreak of pneumonia associated with a novel coronavirus disease 2019 (COVID-19) emerged in Wuhan City, Hubei province, China. The virus that caused the disease was officially named by the World Health Organization (WHO) as the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). According to the high transmission rate of SARS-CoV-2, it became a global pandemic and public health emergency within few months. Since SARS-CoV-2 is genetically 80% homologous with the SARS-CoVs family, it is hypothesized that medications developed for the treatment of SARS-CoVs may be useful in the control and management of SARS-CoV-2. In this regard, some medication being tested in clinical trials and in vitro studies include anti-viral RNA polymerase inhibitors, HIV-protease inhibitors, anti-inflammatory agents, angiotensin converting enzyme type 2 (ACE 2) blockers, and some other novel medications. In this communication, we reviewed the general characteristics of medications, medical usage, mechanism of action, as well as SARS-CoV-2 related trials.

    Search related documents:
    Co phrase search for related documents
    • active form and adenosine analogue: 1, 2, 3
    • active form and administration food: 1, 2, 3, 4
    • active form and liver intestine: 1
    • active form and loading dose: 1
    • active form and lung status: 1
    • active form prodrug and administration food: 1
    • active form prodrug and liver intestine: 1
    • acute ards respiratory distress syndrome and administration food: 1, 2, 3, 4, 5, 6, 7
    • acute ards respiratory distress syndrome and adolescent adult: 1
    • acute ards respiratory distress syndrome and loading dose: 1
    • acute ards respiratory distress syndrome and lopinavir ritonavir: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35
    • acute ards respiratory distress syndrome and lopinavir ritonavir administer: 1
    • acute ards respiratory distress syndrome and low mortality: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24
    • acute ards respiratory distress syndrome and low respiratory: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28
    • acute ards respiratory distress syndrome and low respiratory system: 1, 2, 3
    • acute ards respiratory distress syndrome and lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75
    • acute ards respiratory distress syndrome and lung injury patient: 1, 2, 3, 4, 5, 6
    • acute ards respiratory distress syndrome and lung protect: 1, 2, 3, 4, 5, 6, 7, 8
    • acute ards respiratory distress syndrome and lung status: 1, 2, 3